CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 45 enrolled
Drug / intervention
Bupivacaine +1 moredrug
Likely dose
morphine patient controlled analgesia 1mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02852382
NCT02852382Phase 2Completed
CompareCT.gov

The Effects of Scalp Block on Haemodynamic Response and Postoperative Pain in

Istanbul University·interventional·Posted Aug 2, 2016·Updated Aug 22, 2017

In Brief

A Phase 2 clinical trial evaluating Bupivacaine and morphine patient controlled analgesia for Posterior Fossa Tumors. Completed, enrolled 45 participants.

Detailed Summary

This study evaluate the effects of scalp block versus local infiltration on haemodynamic response to head pin replacement and skin incision and postoperative analgesia in posterior fossa surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPosterior Fossa Tumors
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 2, 2016
Enrollment StartApr 1, 2014
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.9 years ago

Interventions

Bupivacainedrug

In the scalp block and local infiltration arms; bupivacaine %0,5 will be used.

morphine patient controlled analgesiadrug

End of the surgery all of the patients in 3 groups will receive morphine patient controlled analgesia (PCA) including 1mg/ml morphine. The PCA was set to administer a bolus dose of 1 mg on demand with a lockout period of 10 minutes and maximum 25 mg for 4 hours.